These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 23518212)

  • 1. Flecainide versus vernakalant for conversion of recent-onset atrial fibrillation.
    Conde D; Costabel JP; Caro M; Ferro A; Lambardi F; Corrales Barboza A; Lavalle Cobo A; Trivi M
    Int J Cardiol; 2013 Oct; 168(3):2423-5. PubMed ID: 23518212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Propafenone versus vernakalant for conversion of recent-onset atrial fibrillation.
    Conde D; Costabel JP; Aragon M; Lambardi F; Klein A; Corrales Barbosa A; Trivi M; Giniger A
    Cardiovasc Ther; 2013 Dec; 31(6):377-80. PubMed ID: 23683253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vernakalant: Perception of state of health in patients with a recent-onset atrial fibrillation.
    Conde D; Costabel JP; Aragon M; Lambardi F; Trivi M
    Cardiol J; 2014; 21(3):304-8. PubMed ID: 23990184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vernakalant is superior to ibutilide for achieving sinus rhythm in patients with recent-onset atrial fibrillation: a randomized controlled trial at the emergency department.
    Simon A; Niederdoeckl J; Skyllouriotis E; Schuetz N; Herkner H; Weiser C; Laggner AN; Domanovits H; Spiel AO
    Europace; 2017 Feb; 19(2):233-240. PubMed ID: 28175295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conversion of Recent-Onset Atrial Fibrillation: Which Drug is the Best?
    Conde D; Elissamburu P; Lalor N; Rodriguez L; Aragon M; Costabel JP; Lambardi F; Trivi M
    J Atr Fibrillation; 2013; 6(2):910. PubMed ID: 28496882
    [No Abstract]   [Full Text] [Related]  

  • 6. Is vernakalant better or not, compared with other treatments for conversion of acute atrial fibrillation?
    Conde D
    Int J Cardiol; 2013 Oct; 169(2):95-6. PubMed ID: 24071384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological cardioversion of atrial fibrillation with vernakalant: evidence in support of the ESC Guidelines.
    Savelieva I; Graydon R; Camm AJ
    Europace; 2014 Feb; 16(2):162-73. PubMed ID: 24108230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous vernakalant in comparison with intravenous flecainide in the cardioversion of recent-onset atrial fibrillation.
    Pohjantähti-Maaroos H; Hyppölä H; Lekkala M; Sinisalo E; Heikkola A; Hartikainen J
    Eur Heart J Acute Cardiovasc Care; 2019 Mar; 8(2):114-120. PubMed ID: 28849946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of vernakalant hydrochloride injection for rapid conversion of atrial fibrillation.
    Pratt CM; Roy D; Torp-Pedersen C; Wyse DG; Toft E; Juul-Moller S; Retyk E; Drenning DH;
    Am J Cardiol; 2010 Nov; 106(9):1277-83. PubMed ID: 21029824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flecainide or propafenone vs. vernakalant for conversion of recent-onset atrial fibrillation.
    Conde D; Costabel JP; Aragon M; Caro M; Ferro A; Klein A; Trivi M; Giniger A
    Can J Cardiol; 2013 Oct; 29(10):1330.e13. PubMed ID: 23465347
    [No Abstract]   [Full Text] [Related]  

  • 11. A randomized active-controlled study comparing the efficacy and safety of vernakalant to amiodarone in recent-onset atrial fibrillation.
    Camm AJ; Capucci A; Hohnloser SH; Torp-Pedersen C; Van Gelder IC; Mangal B; Beatch G;
    J Am Coll Cardiol; 2011 Jan; 57(3):313-21. PubMed ID: 21232669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemical cardioversion of recent-onset atrial fibrillation in the emergency department using vernakalant hydrochloride achieves safe and rapid restoration of sinus rhythm and facilitates same day discharge.
    Stoneman P; Gilligan P; Mahon P; Sheahan R
    Ir J Med Sci; 2017 Nov; 186(4):903-908. PubMed ID: 28168639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous vernakalant: a review of its use in the management of recent-onset atrial fibrillation.
    Duggan ST; Scott LJ
    Drugs; 2011 Jan; 71(2):237-52. PubMed ID: 21275448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of conversion of recent-onset atrial fibrillation treated with vernakalant.
    Costabel JP; Lambardi F; Aragón M; Campos R; Urdapilleta M; Ariznavarreta P; Vergara JM; Conde D
    Pacing Clin Electrophysiol; 2015 Feb; 38(2):196-200. PubMed ID: 25469647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and efficacy of vernakalant for the conversion of atrial fibrillation to sinus rhythm; a phase 3b randomized controlled trial.
    Beatch GN; Mangal B
    BMC Cardiovasc Disord; 2016 May; 16():113. PubMed ID: 27233239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multicenter, open-label study of vernakalant for the conversion of atrial fibrillation to sinus rhythm.
    Stiell IG; Roos JS; Kavanagh KM; Dickinson G
    Am Heart J; 2010 Jun; 159(6):1095-101. PubMed ID: 20569725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and Safety of Vernakalant for Cardioversion of Recent-onset Atrial Fibrillation in the Asia-Pacific Region: A Phase 3 Randomized Controlled Trial.
    Beatch GN; Bhirangi K; Juul-Moller S; Rustige J
    J Cardiovasc Pharmacol; 2017 Feb; 69(2):86-92. PubMed ID: 27828791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vernakalant hydrochloride to treat atrial fibrillation.
    Brown RA; Lau YC; Lip GY
    Expert Opin Pharmacother; 2014 Apr; 15(6):865-72. PubMed ID: 24617913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy of vernakalant for acute cardioversion of atrial fibrillation: an update.
    Tsuji Y; Dobrev D
    Vasc Health Risk Manag; 2013; 9():165-75. PubMed ID: 23637539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of successful cardioversion with vernakalant in patients with recent-onset atrial fibrillation.
    Mochalina N; Juhlin T; Öhlin B; Carlson J; Holmqvist F; Platonov PG
    Ann Noninvasive Electrocardiol; 2015 Mar; 20(2):140-7. PubMed ID: 25040826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.